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Abstract
Objectives: The utility of nasogastric aspiration and lavage in the emergency management of patients
with melena or hematochezia without hematemesis is controversial. This evidence-based emergency
medicine review evaluates the following question: does nasogastric aspiration and lavage in patients
with melena or hematochezia and no hematemesis differentiate an upper from lower source of gastro-
intestinal (GI) bleeding?
Methods: MEDLINE, EMBASE, the Cochrane Library, and other databases were searched. Studies
were selected for inclusion in the review if the authors had performed nasogastric aspiration (with or
without lavage) in all patients with hematochezia or melena and performed esophagogastroduodenal
endoscopy (EGD) in all patients. Studies were excluded if they enrolled patients with history of esopha-
geal varices or included patients with hematemesis or coffee ground emesis (unless the data for patients
without hematemesis or coffee ground emesis could be separated out). The outcome was identifying
upper GI hemorrhage (active bleeding or high-risk lesions potentially responsible for hemorrhage) and
the rate of complications associated with the nasogastric tube insertion. Quality of the included studies
was assessed using standard criteria for diagnostic accuracy studies.
Results: Three retrospective studies met our inclusion and exclusion criteria. The prevalence of an upper
GI source for patients with melena or hematochezia without hematemesis was 32% to 74%. According
to the included studies, the diagnostic performance of the nasogastric aspiration and lavage for predict-
ing upper GI bleeding is poor. The sensitivity of this test ranged from 42% to 84%, the specificity from
54% to 91%, and negative likelihood ratios from 0.62 to 0.20. Only one study reported the rate complica-
tions associated with nasogastric aspiration and lavage (1.6%).
Conclusions: Nasogastric aspiration, with or without lavage, has a low sensitivity and poor negative
likelihood ratio, which limits its utility in ruling out an upper GI source of bleeding in patients with mele-
na or hematochezia without hematemesis.
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CLINICAL SCENARIO
A75-year-old African American male with thechief complaint of bright red blood per rectumis brought to your emergency department (ED)
via ambulance. The paramedics state that they observed
a toilet bowl filled with red blood without clots. The
patient appeared to the paramedics in no acute distress,
with initial vital signs of blood pressure (BP) 160 ⁄95 mm
Hg, pulse rate (PR) 90 beats ⁄min, and respiratory rate
(RR) 18 breaths ⁄min. At triage the patient is alert and ori-
ented and appears in no acute distress. The blood
appears mixed with stool during three episodes. The
patient denies hematemesis or any associated abdominal
pain. He denies previous episodes of similar bleeding
and has no history of esophageal varices, chronic liver
disease, gastritis, gastroesophageal reflux, gastric or
duodenal ulcers, hemorrhoids, colonic diverticuli, or
gastrointestinal (GI) cancers. He is not taking warfarin,
aspirin, clopidogrel, heparin, or any other blood-thin-
ning agent. He denies recent ingestion of steroids or
ISSN 1069-6563 ª 2010 by the Society for Academic Emergency Medicine
126 PII ISSN 1069-6563583 doi: 10.1111/j.1553-2712.2009.00609.x
From the Department of Emergency Medicine, State University
of New York, Downstate Medical Center, Brooklyn, New York.
Received June 5, 2009; revision received July 27, 2009; accepted
July 28, 2009.
Address for correspondence and reprints: Nicholas Palami-
dessi, MD; e-mail: npdessi@hotmail.com.
nonsteroidal anti-inflammatory drugs. He does not
smoke, drink alcohol, or take illicit drugs. Medical history
is positive only for hypertension.
The patient is placed in a monitored bed, two large-
bore intravenous lines are started, and blood work is
sent for serum lactate level, complete blood count, rou-
tine chemistry panel, coagulation profile, and type and
screen. Physical examination discloses a healthy elder
gentleman in no acute distress. Vital signs include tem-
perature 98.6F, BP 158 ⁄95 mm Hg, PR 90 beats ⁄min,
RR 18 breaths ⁄min, and room air oxygen saturation
100%. No orthostatic BP or pulse changes are noted.
Physical examination is unremarkable. The digital rectal
examination has maroon-color stool and is grossly
guaiac positive. No hemorrhoids, masses, or fistulae are
noted. Initial hemoglobin and hematocrit are 12 g ⁄dL
and 34%, respectively. Serum lactate level is 2.5
mmol ⁄L.
You request consultation with gastroenterology and
surgery. The surgical resident requests a nasogastric
tube to be placed for lavage, as ‘‘I need to know if the
source of bleeding is upper or lower.’’ In addition, ‘‘if
an upper GI bleed is found, a lavage will tell me the
extent of bleeding.’’ After a single unsuccessful attempt
to place the nasogastric tube, the patient refuses subse-
quent attempts. He states, ‘‘That was barbaric. Don’t
come near me again with that tube!’’ After your shift,
discontent with imposing discomfort to your patient by
trying to insert the nasogastric tube, you decide to
examine the evidence behind using nasogastric aspira-
tion and lavage in patients with melena or hema-
tochezia without hematemesis.
INTRODUCTION
Since the first reported insertion of a nasogastric tube
by Hunter in 1790 to feed a paralyzed patient,1 its use
has become routine, including an ever-expanding role
in both therapeutic and diagnostic procedures. The
consultant’s suggestion to insert a nasogastric tube in
the presented case is not an unusual request for localiz-
ing the source of GI bleeding (upper vs. lower).2–4 The
argument supporting this practice is to direct further
diagnosis or treatment strategy (e.g., choice of upper or
lower endoscopy, starting proton pump inhibitors).
Some investigators have also suggested that the ability
to clear the bloody or ‘‘coffee ground’’ aspirate with
lavage might have prognostic value.5 On the other
hand, others have argued that in common practice, the
majority of the patients with melena or hematochezia
without hematemesis undergo both upper and lower
endoscopy anyway, irrespective of the findings of naso-
gastric lavage.
Our patient voices valid concerns about the pain
associated with nasogastric tube insertion. This proce-
dure has been described by patients as one of the most
painful of routine ED procedures.6 The use of preproce-
dural nebulized lidocaine7,8 has only been somewhat
successful at alleviating the pain of nasogastric tube
insertion. Complications with this procedure, although
rare, include epistaxis, pneumothorax, hydrothorax,
empyema, mediastinitis, pneumonia, esophageal perfo-
ration, and vocal cord paralysis.9–11
For an uncomfortable and painful procedure to be
used routinely by emergency physicians the procedure
must yield diagnostic or therapeutic benefits, and the
advantages should outweigh the risks and complica-
tions. Our objective was to answer the following
research question through an evidence-based literature
review: in patients with hematochezia or melena with-
out hematemesis, does nasogastric aspiration and
lavage differentiate an upper from lower source of GI
bleeding sufficiently to justify its routine use?
METHODS
Criteria
To answer the question posed by the clinical scenario,
our formulated question is as follows: what is the utility
of nasogastric aspiration and lavage in identifying
upper GI sources of bleeding in ED patients with hema-
tochezia ⁄melena without hematemesis?
For the purpose of this review, we translated our
research questions into a set of predefined selection
criteria for relevant studies. In defining the target popu-
lation, we intended to study ED patients with melena
(black tarry stool) or hematochezia (bloody or maroon-
colored stool), without hematemesis (vomiting bright
red blood or coffee ground material).
We chose nasogastric aspiration (with or without a
lavage) as the intervention. The nasogastric tube is a
stomach tube placed through the nose and aspirated
for blood, followed by slow lavage of room tem-
perature water or saline. Diagnostic value of this
intervention or test mostly relies on visualization of
gross blood or coffee ground aspirate (to rule in the
upper GI bleeding) or visualization of bile (to rule out
upper GI bleeding). Upper GI bleeding refers to hemor-
rhage originating proximal to the ligament of Treitz.
Inability to clear the stomach contents after determin-
ing the upper GI bleeding as the source of melena or
hematochezia is generally interpreted as evidence of
continuous bleeding.
The primary outcome was the operating characteris-
tics (sensitivity, specificity, predictive values, and likeli-
hood ratios) of nasogastric aspiration and lavage for
identifying an upper GI source for the hemorrhage. The
secondary outcome was the rate of complications
associated with the procedure, including hemorrhage,
aspiration, esophageal perforation, hemo- or pneumo-
thorax, etc.
We considered esophagogastroduodenal endoscopy
(EGD) as the reference standard test for identifying the
source of bleeding. EGD can either visualize active
bleeding or identify high-risk lesions likely to be respon-
sible for the bleeding (e.g., visible vessel in an ulcer, a
mass, a clot, or inflamed endothelium). Other acceptable
alternatives include colonoscopy, radio nucleide scan-
ning, arteriography, or surgery when the lower GI
source for the bleeding was successfully identified.
Keeping the details of our research questions in mind,
our criteria for selecting the studies were as follows:
Participants. Participants included ED patients present-
ing with melena or hematochezia without hematemesis.
We included studies that specifically stated they
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excluded patients with known esophageal varices or
those suspected of variceal bleeding because nasogas-
tric tube insertion is felt by some to be relatively contra-
indicated. We also excluded studies with patients who
had hematemesis or coffee ground emesis, because an
upper GI source for the bleeding is already evident.
Intervention ⁄ test. Nasogastric tube was inserted with
aspiration (with or without lavage).
Outcome. The primary outcome measure was the oper-
ating characteristics of nasogastric aspiration in identi-
fying upper GI bleeding in the target population.
Target study design. The diagnosis arm included the
following: cross-sectional studies that enrolled patients
who received both nasogastric aspiration and lavage
and the reference standard.
Search
We searched the MEDLINE database from 1966 to
November 2008, and EMBASE from 1980 to November
2008. We also scanned the databases of the Cochrane
Library through 2008,12 Emergency Medical Abstracts
from 1977 through November 2008,13 and online
resources including BestBETS.14 We reviewed the bibli-
ographies of the eligible trials for citations of additional
eligible studies. Our MEDLINE and EMBASE search
strategies are presented in Data Supplement S1 (avail-
able as supporting information in the online version of
this paper).
These searches yielded 969 studies, which were then
further reduced according to the algorithm given in
Figure 1. We identified four observational studies that
met our selection criteria.15–18 We excluded one study16
because the results of the reference standard test (EGD)
was not reported in patients with negative nasogastric
aspirates. Also, 18% of patients with positive nasogas-
tric aspirates did not receive EGD.16 One study15
included patients with hematemesis, but after contact-
ing the authors, we were able to separate out patients
without hematemesis.
After the exclusions, we based our review on three
studies.15,17,18 We did not find any systematic reviews
or meta-analyses on this subject. All three studies
included in our review had retrospective designs. The
descriptions of the included studies are summarized in
Table 1.
We used the published standard criteria for reporting
of diagnostic accuracy studies (STARD)19 to evaluate
the quality of the studies selected for this review. We
specifically focused on sampling, design, test measure-
ment, blinding of operators, reference standard, and
estimate of diagnostic accuracy. The results of the qual-
ity assessment of the included studies are summarized
in Table 2.
All studies were performed in a retrospective man-
ner. Blinding was only obtained in one study18 via
blinding of data abstractors. The choice of reference
standard varied in each of the three included studies.
Aljebreen et al.15 used EGD evidence of a high-risk
lesion as their reference standard. This study defined a
high-risk lesion as visualization of an active bleeding
vessel, oozing vessel, or a visible vessel. Cappell17 con-
sidered active bleeding, stigmata of recent bleeding, or
obvious significant lesion on EGD as evidence of upper
GI bleeding. Finally, Witting et al.18 used a combination
of information obtained from reviewing the hospital
discharge summary, EGD, radionucleotide scans, angi-
ography, or surgery as the reference standard.
Although the reference standards used in these studies
are different, they all reasonably support the presence
of an upper GI source for the bleeding.
The estimate of diagnostic accuracy was presented as
sensitivity and specificity in all three studies. Unfortu-
nately, the retrospective design of the three included
studies subjects them to various biases. These biases
originate from missing data, unequal distribution of
patients in the study groups, clinical heterogeneity of
groups, and other flaws inherent to retrospective
reviews.20
RESULTS
The included studies reported a very wide range for
prevalence of an upper GI source for patients with
melena or hematochezia without hematemesis. The rate
of upper GI bleeding in the selected population was
Figure 1. The process of selecting studies suitable for inclu-
sion in the final review.
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32% (95% confidence interval [CI] = 26% to 38%) for
the study by Aljebreen et al.,15 74% (95% CI = 62% to
83%) in the study by Cappell,17 and 50% (95% CI = 43%
to 56%) in the study by Witting et al.18 This wide range
could originate from the differences in patient popula-
tions and also is likely to be due to selection bias in
subject enrollment. It should also be noted that the
study by Cappell17 only enrolled patients with myo-
cardial infarction who were experiencing melena or he-
matochezia. Patients with a myocardial infarction are a
higher risk than the general population for upper GI
bleeding because of higher rates of aspirin use.
Thirty-four percent of the enrolled patients were on
daily aspirin, and another one-third were on heparin or
warfarin.17 Additionally, this study only included
patients from a monitored setting, which consisted of
patients from the ED, intensive care unit, and cardiac
care units and was not specific to ED patients alone.17
According to the included studies, the diagnostic per-
formance of the nasogastric aspiration and lavage for
predicting upper GI bleeding is fairly poor (Table 3).
The sensitivity of this test ranged from 42% to 84%,
and the specificity from 54% to 91%. Among the
included studies, Cappell17 reported the highest sensi-
tivity, and the study by Witting et al.,18 the highest
specificity (Figure 2). An extra source of interstudy
Table 1
Description of Studies Included in the Review
Study Population Test Interpretation Reference Standard
Aljebreen
et al., 200415
• Inclusion: patients with
hematemesis, melena, or
hematochezia who received both
NGA and EGD (data obtained
from a Canadian registry).
• Exclusion: those who did not
undergo NGA.
• n = 526 enrolled patients; 232
had only melena or
hematochezia as their presenting
complaint (no hematemesis).*
• Age (mean ± SD): 66 ± 16.
• Sex: 62% male.
• Positive: coffee ground or bright
red blood.
• Negative: clear or bile-stained
aspirate.
EGD
Cappell, 200517 • Inclusion: patients with
myocardial infarction who
developed hematemesis,
melena, bright red blood in
stool, and patients with positive
fecal occult blood test with
either severe anemia (hematocrit
<30) or hypotension (only data




• Exclusion: 1) NGA for other
reasons; 2) age < 21 years; 3)
orogastric tubes, 4)
nonmonitored setting (CCU, ICU,
or ED); 5) NGA for fecal occult
blood without other criteria.
• n = 66.
• Age (mean and SD): 73 ±10.
• Sex: 66% male.
• Positive: visualization of red
blood or coffee ground aspirate.





• Inclusion: patients with bloody,
dark, or black stools; admission
through the ED; confirmatory
testing within 3 days; age
>17 years; and absence of
hematemesis.
• Exclusion: presence of ostomy,
obvious anorectal source,
admission for GI bleeding within
previous month.
• n = 235.
• Age: 69% less than 50 years of
age.
• Sex: unable to extract data.
• Results coded in six categories:
clearly negative, somewhat
negative, questionably positive
(flecks of blood, 30 mL), mildly
positive (coffee ground or bright
red blood, 30–450 mL),
moderately positive (coffee
ground >450 mL, or difficulty
clearing), strongly positive
(bright red blood >450 mL with
difficulty clearing).
Hospital course and results of
EGD, radionucleotide scans,
angiography, and surgery.
CCU = cardiac care unit; EGD = esophagogastroduodenoscopy; GI = gastrointestinal; ICU = intensive care unit; NGA = nasogas-
tric aspiration.
*Only patients with melena or hematochezia were included in the review (data provided in the article or by the authors after
contacting them).
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variability may have resulted from their varying defini-
tions of a positive endoscopy, which include a wide
range of definitions, from a visibly bleeding vessel, to
only an ulcer that was assumed to be the source of
upper GI hemorrhage.
It must be noted that the likelihood ratios presented
in Table 3 for Witting et al.18 are different from the
ones presented in the original article because we used
different definitions for calculating the likelihood ratios.
In our calculations, we used a more conservative
approach to account for cases that did not undergo
nasogastric aspiration. We considered the test results
false negative if the EGD reported a positive upper GI
source or as false positive if the EGD was negative.
However, in the original article,18 the authors used a
different method for calculating the likelihood ratios
and still counted the aborted cases (patients who did
not have nasogastric aspiration) in their calculations by
using a 3 · 2 table. This method yielded a negative like-
lihood ratio of 0.6 and a positive likelihood ratio of 11.0
(compared to 0.7 and 4.4, respectively, by our conserva-
tive method [Table 3]).
Finally, only one study reported the complications
associated with nasogastric aspiration and lavage. One
patient reportedly had gastric erosions resulting from
suctioning, and another experienced epistaxis.17
APPLYING THE EVIDENCE
Nasogastric tube insertion is a common procedure per-
formed in the ED around the world and is frequently
requested by the consulting services for cases similar
Table 3
Operating Characteristics of Nasogastric Aspiration and Lavage in Diagnosing Upper GI Hemorrhage in Patients With Hematochezia








% (95% CI) LR+ LR–
Aljebreen et al., 200415* 68 (57–78) 54 (45–61) 41 (33–50) 78 (69–85) 1.44 0.61
Cappell, 200517 84 (70–93) 82 (57–96) 93 (81–98) 64 (43–80) 4.74 0.2
Witting, et al., 200418 42 (32–51) 91 (83–95) 81 (69–90) 61 (53–68) 4.44 0.65
GI = gastrointestinal; LR+ = likelihood ratio of a positive test; LR– = likelihood ratio of a negative test; NPV = negative predictive
value; PPV = positive predictive value.
*Information obtained by contacting authors.
Table 2
Quality Assessment of the Included Studies
Aljebreen et al., 200415 Cappell, 200517 Witting et al., 200418
Sampling Consecutive sample Convenience sample Convenience sample




bloody, clear ⁄bile, or other
Identifying coffee ground, bright
red blood, or clear
Identifying NGA color based on six
classifications: clearly negative,
somewhat negative, questionably
positive (flecks of blood: at least
30 mL), mildly positive (coffee
ground or bright red blood,
30–450 mL), moderately positive
(coffee ground >450 ml, or
difficulty clearing), strongly




Not blinded Not blinded Data abstractors were blinded to
specific aims of the study and test
measurement. The results of the
reference standard test were




EGD for identifying high-risk
lesions (active bleeding vessel,
oozing vessel, or visible vessel)
EGD (active bleeding, stigmata of









Sensitivity ⁄ specificity, and
NPV ⁄PPV
Sensitivity and specificity (for
overall subjects, not specified for
melena or hematochezia)





95% CI 95% CI 95% CI, LR
EGD = esophagogastroduodenoscopy; GI = gastrointestinal; LR = likelihood ratios; NGA = nasogastric aspiration; NPV = negative
predictive value; PPV = positive predictive value.
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to the patient in our scenario. Nasogastric aspiration
and lavage is a diagnostic test often taken for granted
in its safety and comfort to the patient. This procedure
has been associated with a multitude of serious compli-
cations as discussed earlier.9–11 Pillai et al.21 found
complication rates from nasogastric tube placement
varying from 0.3% to 0.8%. Considering the frequency
in which nasogastric tube insertion occurs worldwide,
the number of complications is not insignificant. In
addition, this test has been rated among the most pain-
ful and uncomfortable ED procedures.6 Because the
procedure is not completely benign and does cause
marked discomfort to the patient, we must consider
whether the use of this procedure is justified in
patients presenting with melena or hematochezia with-
out hematemesis.
Nasogastric aspiration and lavage is used as a poten-
tial screening test in the ED to differentiate upper from
lower GI hemorrhage. For a screening test to be useful,
it should have the characteristics of a high sensitivity,
low negative predictive value, and low negative likeli-
hood ratio. The included studies found that nasogastric
aspiration and lavage carry a low sensitivity (42% to
84%), a high negative predictive value (61% to 78%),
and a relatively poor negative likelihood ratio (0.65 to
0.2).
Given these heterogeneous results from our studies,
the value of nasogastric aspiration and lavage is far
from certain. From the operating characteristics of
nasogastric aspiration and lavage it appears that all
sensitivities are below 90%, and negative likelihood
ratios are greater than 0.2, resulting in a negative pre-
dictive value of less than 78%; it is unlikely that a nega-
tive nasogastric aspiration and lavage should change
the clinical management of patients with melena or
hematochezia without hematemesis.
An aspirate positive for fresh blood or coffee ground
materials is also not conclusive for a diagnosis of upper
GI bleeding. It only increases the odds of an upper GI
source by a factor of 1.44 to 4.74 times (positive likeli-
hood, Table 3). The heterogeneity of the operating char-
acteristics may be related to the criteria used to define
a positive or negative aspirate. A false-negative aspirate
could be caused by an inadequate lavage volume or
inability to identify bile in the lavage fluid. A false-posi-
tive result could result from an overzealous definition
of ‘‘bright red blood’’ in lavage, return of just flecks of
blood, or just ‘‘coffee grounds.’’
The heterogeneity of diagnostic characteristics
among these studies is related to variations in the study
populations. Variation in disease prevalence is well
known to affect predictive values, but may also affect
sensitivity. Study populations with high disease preva-
lence tend to have patients with a more severe form of
the disease. In this case, subjects with more active
lesions are more likely to be correctly identified, inflat-
ing the sensitivity (spectrum bias).22 We see this effect
between our three trials, with the study by Cappell,17
with the highest disease prevalence (74%), having a sig-
nificantly higher sensitivity (84%) than the other two
studies.
Now consider our clinical scenario of an elder gentle-
man who presents with hematochezia without hemate-
mesis. He appears by vital signs and initial blood work
to be hemodynamically stable. Our surgery consultant
requested a nasogastric aspiration and lavage to differ-
entiate an upper from lower GI source of bleeding. By
examining the evidence, we can conclude that a nega-
tive nasogastric aspiration and lavage does not possess
an adequate sensitivity or an acceptable negative likeli-
hood to comfortably rule out an upper GI bleed. The
question remains: is the nasogastric aspiration still
worthwhile if gross blood or coffee grounds are found?
This would seem to depend upon a discussion between
the emergency physician and the gastroenterologist as
to the value of emergent or delayed endoscopy in such
a patient; there seem to be diverging opinions on this
topic.23–25 If the gastroenterologist plans on performing
an emergent EGD if the nasogastric aspirate reveals
gross blood or coffee ground material, placing a naso-
gastric tube might be worthwhile, at least by expediting
the patient work-up. If the nasogastric aspirate is not
going to prompt emergent EGD for a stable patient
with a suspected upper GI bleeding, then the need for
nasogastric tube is obviated. A negative or positive
nasogastric aspirate and lavage will not change the
diagnostic pathway for such a patient. The patient can
then simply be managed with a nonemergent upper
and lower endoscopy, without subjecting him or her to
a nasogastric tube.
CONCLUSIONS
Nasogastric aspiration and lavage has a low sensitivity
and relatively poor negative likelihood ratio to be useful
in ruling out an upper gastrointestinal source in
patients with melena or hematochezia without hemate-
mesis. This test cannot be used to obviate or delay
upper endoscopy in such patients, and therefore it does
not change the management. A coordinated plan by
emergency physician and the gastroenterologist as to
whether nasogastric aspiration changes the timing of
endoscopy should also be taken into consideration
before nasogastric tube insertion.
Figure 2. Summary of the results of the included studies representing the operating characteristics of nasogastric aspiration in
identifying upper GI hemorrhage in patients with hematochezia or melena without hematemesis.*For each trial, the square corre-
sponds to the observed sensitivity or specificity, and the horizontal line defines the 95% CI. FN = false negative; FP = false positive;
GI = gastrointestinal; TN = true negative; TP = true positive.
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